230 related articles for article (PubMed ID: 29475034)
1. Stable-State Midrange Proadrenomedullin Is Associated With Severe Exacerbations in COPD.
Citgez E; Zuur-Telgen M; van der Palen J; van der Valk P; Stolz D; Brusse-Keizer M
Chest; 2018 Jul; 154(1):51-57. PubMed ID: 29475034
[TBL] [Abstract][Full Text] [Related]
2. Stable State Proadrenomedullin Level in COPD Patients: A Validation Study.
Zuur-Telgen M; VanderValk P; van der Palen J; Kerstjens HA; Brusse-Keizer M
COPD; 2017 Apr; 14(2):219-227. PubMed ID: 27880050
[TBL] [Abstract][Full Text] [Related]
3. Stable-State Midrange-Proadrenomedullin Level Is a Strong Predictor of Mortality in Patients With COPD.
Zuur-Telgen MC; Brusse-Keizer MG; VanderValk PD; van der Palen J; Kerstjens HA; Hendrix MG
Chest; 2014 Mar; 145(3):534-541. PubMed ID: 27845633
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin optimises mortality prediction in COPD patients.
Brusse-Keizer M; Zuur-Telgen M; van der Palen J; VanderValk P; Kerstjens H; Boersma W; Blasi F; Kostikas K; Milenkovic B; Tamm M; Stolz D
Respir Med; 2015 Jun; 109(6):734-42. PubMed ID: 25937049
[TBL] [Abstract][Full Text] [Related]
5. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
[TBL] [Abstract][Full Text] [Related]
6. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M
Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
[TBL] [Abstract][Full Text] [Related]
8. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.
Huang DT; Angus DC; Kellum JA; Pugh NA; Weissfeld LA; Struck J; Delude RL; Rosengart MR; Yealy DM
Chest; 2009 Sep; 136(3):823-831. PubMed ID: 19363212
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
[TBL] [Abstract][Full Text] [Related]
10. Mid-regional proadrenomedullin: An early marker of response in critically ill patients with severe community-acquired pneumonia?
Pereira JM; Azevedo A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
Rev Port Pneumol (2006); 2016; 22(6):308-314. PubMed ID: 27160747
[TBL] [Abstract][Full Text] [Related]
11. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352
[TBL] [Abstract][Full Text] [Related]
12. Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin.
Stolz D; Boersma W; Blasi F; Louis R; Milenkovic B; Kostikas K; Aerts JG; Rohde G; Lacoma A; Rakic J; Boeck L; Castellotti P; Scherr A; Marin A; Hertel S; Giersdorf S; Torres A; Welte T; Tamm M
Chest; 2014 Aug; 146(2):328-338. PubMed ID: 24722847
[TBL] [Abstract][Full Text] [Related]
13. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.
Bello S; Lasierra AB; Mincholé E; Fandos S; Ruiz MA; Vera E; de Pablo F; Ferrer M; Menendez R; Torres A
Eur Respir J; 2012 May; 39(5):1144-55. PubMed ID: 22075489
[TBL] [Abstract][Full Text] [Related]
14. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H
Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
[TBL] [Abstract][Full Text] [Related]
15. Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review.
Cavallazzi R; El-Kersh K; Abu-Atherah E; Singh S; Loke YK; Wiemken T; Ramirez J
Respir Med; 2014 Nov; 108(11):1569-80. PubMed ID: 25448309
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
[TBL] [Abstract][Full Text] [Related]
17. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.
Wild PS; Schnabel RB; Lubos E; Zeller T; Sinning CR; Keller T; Tzikas S; Lackner KJ; Peetz D; Rupprecht HJ; Bickel C; Morgenthaler NG; Papassotiriou J; Tiret L; Münzel T; Blankenberg S
Clin Chem; 2012 Jan; 58(1):226-36. PubMed ID: 22065157
[TBL] [Abstract][Full Text] [Related]
18. Predicting Mortality in COPD with Validated and Sensitive Biomarkers; Fibrinogen and Mid-Range-Proadrenomedullin (MR-proADM).
Zuur-Telgen MC; Citgez E; Zuur AT; VanderValk P; van der Palen J; Kerstjens HAM; Brusse-Keizer M
COPD; 2021 Dec; 18(6):643-649. PubMed ID: 34886719
[TBL] [Abstract][Full Text] [Related]
19. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
[TBL] [Abstract][Full Text] [Related]
20. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]